[Business Wire] – Exelixis, Inc. today announced the appointment of Jeffrey J. Hessekiel, J.D., as executive vice president and general counsel. Mr. Hessekiel is a veteran legal professional with more than a decade of experience in the biopharmaceutical moreView todays social media effects on EXELView the latest stocks trending across Twitter. Click to view dashboardSee who Exelixis is hiring […]
[at noodls] – More news 2013-02-22 Contact: Charles Butler Vice President, Investor Relations and Corporate Communications Exelixis, Inc….This is an abstract of the original noodl. To continue reading this document, … moreView todays social media effects on EXELView the latest stocks trending across Twitter. Click to view dashboardSee who Exelixis is hiring next, click here to view […]
[ACN Newswire] – By David Sobek Exelixis (NASDAQ:EXEL) has a Prescription Drug User Fee Act (PDUFA) action date on November 29 th , 2012 for cabozantinib as a treatment for patients with progressive, unresectable, locally … moreView todays social media effects on EXELView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By Jake KingExelixis (NASDAQ:EXEL) Thursday is retracing some of its losses from the beginning of the week and is up 10% from yesterday’s close, to $5.00, due in part to short-covering. The stock, however, … moreView todays social media effects on EXELView the latest stocks trending across Twitter. Click to view dashboard […]
